High Concentrations of Rosiglitazone Reduce mRNA and Protein Levels of LRP1 in HepG2 Cells

Por Rondón-Ortiz, Alejandro N., Lino Cardenas, Christian L., Martínez-Málaga, Jimena, Gonzales-Urday, Ana L., Gugnani, Kuljeet S., Böhlke, Mark, Maher, Timothy J., Pino-Figueroa, Alejandro J.
Publicado no Front Pharmacol (2017)